GLATIRAMER ACETATE (GA) IS COST-EFFECTIVE COMPARED TO INTERFERONS AND BEST SUPPORTIVE CARE (BSC) FOR RELAPSING REMITTING MULTIPLE SCLEROSIS (RRMS) IN THE UK

Author(s)

Maervoet J¹, Ivanescu C², Wu Y³, van Engen A²
¹Quintiles Advisory Services, Brussels, Belgium, ²Quintiles Advisory Services, Hoofddorp, The Netherlands, ³Teva Branded Pharmaceuticals Products R&D Inc, Frazer, PA, USA

Presentation Documents

PND50--strong-u-maervoet-j-u-sup-1-sup-strong-ivanescu-c-sup-2-sup-wu-y-sup-3-sup-van-engen-a-sup-2-sup-br-sup-1-sup-quintiles-advisory-services-brussels-belgium-sup-2-sup-quintiles-advisory-services-hoofddorp-the-netherlands-sup-3-sup-teva ...

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PND50

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Neurological Disorders

Explore Related HEOR by Topic

Economic Evaluation

Presentation